A 12‐week open‐label pilot study of donepezil for cognitive functioning and instrumental activities of daily living in late‐life bipolar disorder
- 3 January 2008
- journal article
- research article
- Published by Wiley in International Journal of Geriatric Psychiatry
- Vol. 23 (7) , 693-698
Abstract
Objective: To determine whether donepezil is effective in enhancing cognitive functioning and instrumental activities of daily living (IADLs) in older adults with bipolar disorder.Methods: Twelve elderly patients with bipolar I or II disorder, with evidence of mild cognitive decrements, were administered donepezil 5–10 mg daily for 3 months. Participants had cognitive and functional evaluation pre‐, on‐, and 3‐months post donepezil administration.Results: Three subjects dropped out of the study. In the remaining nine subjects, no significant effects were observed in cognitive and functional measures. Seven of the nine participants asked to resume the medication after completion of the study because of the perceived beneficial effects.Conclusions: In this small pilot study of older adults with bipolar disorder, acute treatment with donepezil was not associated with improvements in cognitive and IADL functioning. Given limitations of the study design, placebo effects could not be ruled out in the subjects who asked to resume donepezil. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 18 references indexed in Scilit:
- Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjectsJournal of Affective Disorders, 2007
- Oral Cholinesterase Inhibitor Add-on Therapy for Cognitive Enhancement in SchizophreniaClinical Neuropharmacology, 2007
- Galantamine treatment of cognitive impairment in bipolar disorder: four casesBipolar Disorders, 2006
- Evolution of cognitive impairment in bipolar disorder: a systematic review of cross‐sectional evidenceBipolar Disorders, 2006
- Pharmacological Modulation of Prefrontal Cortical Activity During a Working Memory Task in Young and Older Humans: A PET Study With PhysostigmineAmerican Journal of Psychiatry, 2005
- Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for PennsylvaniansBipolar Disorders, 2005
- Vitamin E and Donepezil for the Treatment of Mild Cognitive ImpairmentNew England Journal of Medicine, 2005
- Cognitive Functioning in Late-Life Bipolar DisorderAmerican Journal of Psychiatry, 2004
- Psychoactive Drugs and Pilot Performance: A Comparison of Nicotine, Donepezil, and Alcohol EffectsNeuropsychopharmacology, 2003
- The UKU side effect rating scale: A new comprehensive rating scale for psychotropic drugs and a cross‐sectional study of side effects in neuroleptic‐treated patientsActa Psychiatrica Scandinavica, 1987